Background: Second primary malignancies (SPMs) after liver transplantation (LT) are
becoming the leading causes of death in LT recipients. The purpose of this study was to …

Liver transplant recipients receive immunosuppressive treatment to avoid organ rejection,
increasing the risk of developing de novo cancer after transplantation. We investigated the …

Background To investigate the incidence and potential predictors of immune tolerance
among adult living donor liver transplant (LDLT) recipients. Methods This case-control study …

Objective: To determine the nationwide prevalence of malignant neoplasms (excluding
hepatocellular carcinoma-HCC) in hospitalized liver transplant recipients and to study the …

Background: De novo tumors after liver transplantation are recognized as a major cause of
longterm mortalities. Ampulla of Vater tumor is a relatively uncommon tumor among all …